ABOUT HEMNET

The Hemophilia Eastern Mediterranean Network (HEMNET) is a network of leading all healthcare professionals established in December 2017 under the umbrella of the World Federation of Hemophilia (WFH).

HEMNET Steering Committee (SC)
SC Chair Magdy El-Ekiaby Egypt
SC Regional Members
  • Mustapha Al-Falah
  • Claudia Khayat
  • Mohammed El-Khorassani
  • Tahira Zafar
  • Tarek Owaidah
  • Emna Gouider
  • Jordan
  • Lebanon
  • Morocco
  • Pakistan
  • Saudi Arabia
  • Tunisia
SC International Members
  • Glenn Pierce
  • Flora Peyvandi
WFH Vice President, Medical University Of Milan

ABOUT THE 2022 HEMNET FORUM

HEMNET is organizing its Fourth Annual HEMNET Forum. The Forum will take place at the Barcelo Hotel in Morocco, Casablanca on November 3 - 5, 2022. Target Audience includes all healthcare professionals interested to the bleeding disorders from all countries.

Fourth HEMNET Forum 2022 Scientific/Organizing Committee
Forum Chair Mohamed El Khorassani Morocco
Forum Scientific Committee
  • Emna Gouider
  • Magdy El-Ekiaby
  • Tarek Owaidah
  • Claudia Khayat
  • Tahira Zafar
  • Salim Nekkal
  • Ahmed Tarawa
  • Yasser Wali
  • Tahani Ali
  • Murtadha Hassen
  • Tunisia
  • Egypt
  • Saudi Arabia
  • Lebanon
  • Pakistan
  • Algeria
  • Saudia Arabia
  • Oman
  • Syria
  • Irak
Forum Organizing Committee
  • Rana Saifi
  • Hassan Mrani Alaoui
  • Emna Gouider
  • Mohamed El khorassani
  • Zineb Benbrahim
  • WFH Regional Manager, Middle East
  • Moroccan hemophilia association
  • Tunisia
  • Morocco
  • Morocco
Registration for 4th HEMNET Forum

Please save the date and register as soon as possible to confirm your presence

Abstract Submission

You can still introduce modifications until Octobre 9th, 2022, 12:00am, by login to your session

AGENDA
  • 03 Nov
  • 04 Nov
  • 05 Nov
Opening Ceremony
19:00 - 20:00
Opening Ceremony and Exhibition Opening

Chair of the 4th HEMNET Forum - Mohammed El-Khorassani (Morocco)
Chair of the HEMNET Group - Magdy El-Ekiaby (Egypt)
President of AMH - Lahsen Mrani Alaoui (Morocco)
WFH Chief Executive Office - Alain Baumann (Canada)
Ministry of Health and Social Protection of Morocco

20:00
DINNER
  • SESSION I
  • SESSION II
  • SESSION III
  • SESSION IV

Life Journey of a PWH: Personalized Treatment

The Beginning: Infancy and Hemophilia in the Pediatric Age
Moderator : Emna Gouider (Tunisia)
08:30 - 09:30
Initiating Treatment: A Doctor’s Decision (3 Clinical Presentations)

Miftah Al-Sahati (Libya) Hadeel Saleh (Kuwait)
Selim Nekkal (Algeria

09:30 - 10:00
PANEL DISCUSSION: When to Start Therapy? What Protocols to Follow?

10:00 - 10:30
COFFEE BREAK
SESSION II - Adolescence
Moderators : Mohammed Khorassani(Morocco) & Mona Hamdy (Egypt)
10:30 - 10:45 Jihane Belayachi (Morocco)
Challenges of Transition from Pediatric to Adult HTCs: The Experience of Morocco

10:45 - 11:10 Federica Cassis (Brazil)
Psycho-Social Challenges and Considerations for Adolescents

11:10 - 11:40 Walid Saied (Tunisia)
How to Manage MSK Complications in Adolescents and Young Adults – A Surgeon’s Perspective

11:40 - 12:00
Discussion

12:00 - 13:00 Emna Gouider (Tunisia)
LUNCH INDUSTRY SYMPOSIUM - AMANY’S PHARMA

Immune Tolerance Induction (ITI)

13:00 - 15:00
PRAYER BREAK (Mosque Hassan 2)
SESSION III - Inhibitors
Moderators : Rhizlane Berrady (Morocco) and Tahira Zafar (Pakistan)
15:00 - 15:15 Tarek Owaidah (Saudi Arabia)
Diagnosis and Management of Acquired Hemophilia: What is the Region’s experience

15:15 - 15:25 Mohsen Al-Alfy (Egypt)
Egypt’s Experience in ITI

15:25 - 15:40 Magdy El-Ekiaby (Egypt)
How is Emicizumab Used in the Eastern Mediterranean Region? Real Life Issues

15:40 - 16:00
Moderated Discussion

16:00 - 17:00 Alok Srivastava (India)
INDUSTRY SYMPOSIUM 3 (ROCHE)

Real World Data Responses to Key Clinical Questions Relating to Haemophilia A Management

17:00 - 17:15
COFFEE BREAK
SESSION IV - Adulthood and Ageing in the Era of Different Therapeutics
Moderators : Nisrine Khoubila (Morocco) & Ahmad Tarawah (Saudi Arabia)
17:15 - 17:35
Lifestyles in the Young Adult Stage – Marriage / Work and Employment: How Can HTCs support PWH?

HTC perspective -- Frederica Cassis (Brazil)
PWH Perspective -- Walid Qubaisi (UAE)

17:35 - 17:55 Ali Taher (Lebanon)
Living Longer: Ageing Complications

17:55 - 18:15 Kaouther Zahra (Tunisia)
How to Manage MSK Complications in Adolescents and Young Adults: A Physiotherapist’s Perspective

18:15 - 18:30
Moderated Discussion

20:00
DINNER
  • SESSION V
  • SESSION VI
  • SESSION VII
  • SESSION VIII
  • SESSION IX
  • SESSION X

Rare Bleeding Disorders

SESSION V - Women with Bleeding Disorders: Clinical Case Studies
Moderator : Claudia Khayat (Lebanon), Anis Fadhlaoui (Tunisia), Frederica Cassis (Brazil)
8:30 - 10:30
Clinical Case presentations and Moderated discussion :

FXIII Deficiency - Tahani Ali (Syria)
Afibrinogenemia - Claudia Khayat (Lebanon)
Glanzmann Thrombasthenia - Ons Ghali (Tunisia)
VWD Type 3 - Tahira Zafar (Pakistan)

10:30 - 11:00
COFFEE BREAK
SESSION VI - WFH Session
Moderator : Alain Baumann
11:00 - 11:20 Emily Ayoub (Canada)
The WFH World Bleeding Disorders Registry (WBDR)

11:20 - 11:30
DISCUSSION

SESSION VII - Von Willebrand Disease (VWD)
Moderators : Magdy El-Ekiaby (Egypt)
11:30 - 11:45 Claudia Khayat (Lebanon)
Education, Outreach and Diagnosis & Treatment (Survey on Country Experiences)

11:45 - 12:00 Jolana Schmiedl (Switzerland)
Do Obstetricians Know About VWD

12:00 - 12:30
Panel Discussion: How to Adapt the recent VWD Guidelines to Contexts of Developing Countries?

12:30 - 12:45
BREAK
12:45 - 13:45 Chairman: Mohamed Elkhorassani (Morocco)
LUNCH SYMPOSIUM -CSL BEHRING

Status of Rare Hemostasis Disorders in the Middle East: How Do We Keep Up with the Times?
Introduction - Mohamed El Khorassani
Current Models of Hemophilia Care in Middle East - Magdy Ekiaby (Egypt)
VWD: Need for Better Diagnosis and Management - Claudia Khayat (Lebanon)
Overview of Congenital Dysfibrinogenemia - Emna Gouider (Tunisia) Q&A session: Panelists

SESSION VIII - Rare Bleeding Disorders: Multi HTC Clinical Cases
Moderators : Nawal Al Mashaykhi (Oman) and Houssein Mahmal (Morocco)
13:45 - 15:05
Clinical Case Presentations and Moderated Discussion

Factor VII - Sarra Benmiloud (Morocco)
Fibrinogen - Claudia Khayat (Lebanon)
Factor XIII - Akbar Dorgalaleh (Iran)
Factor X - Safaa Mohammad (Iraq)

13:45 - 15:05
Clinical Case presentations and Moderated discussion (20 min each):

Factor VII -- Sara Benmiloud (Morocco)
Fibrinogen -- Claudia Khayat (Lebanon)
Factor XII -- Akbar Dorgalaleh (Iran)
Factor X -- Safaa Mohammad (Iraq)

15:05 - 15:35 Steve Austin (United Kingdom)
INDUSTRY SYMPOSIUM - BPL:

Factor X Deficiency

15:35 - 16:00
COFFEE BREAK
SESSION IX - Best Submitted Abstracts
Moderators : Mustapha Al-Falah (Jordan) and Assad Haffar (WFH)
16:00 - 17:30
Abstract Presentations

Hemophilic Arthropathy: Objective Scores for Assessment - Ilham Youssry (Egypt)
Menorrhagia in Egyptian Adolescent Girls with Inherited Bleeding Disorders: A Single Centre Study - Magy Abdelwahab (Egypt)
Difficulty of Hemophilia Care in Developing Countries: Experience of the Hemophilia Centre at the Mohammed VI University Hospital in Marrakech - Rajaa Tissir (Morocco)
Pediatric Population of PWH at the Hemophilia Treatment Center of Aziza Othmana Hospital - Sarra Fekih Salem (Tunisia)
Low dose Prophylaxis: After 10 Years of Follow-up - Ons Ghali (Tunisia)
Molecular Defects of Congenital Deficiencies of Fibrinogen in Tunisia - Hejer Elmahmoudi (Tunisia)
Acquired Hemophilia “A” Associated with Anti-Phospholipid Syndrome: A Case Report - Rajaa Tissir (Morocco)

SESSION X – Closing Session
17:30 - 17:45
CLOSING SESSION
20:00
DINNER
CONTACT

For assistance contact HEMNET conference secretariat

HEMNET 2022 Secretariat

M. Haroun Bizid

Mobile : +212 777 280 378

WhatsApp number : +212 777 280 378

Email : secretariat@hemnetforum.com

Warm Regards

The HEMNET FORUM 2022 Steering Committee